Prescription psychostimulants for cocaine use disorder: A review from molecular basis to clinical approach
Addiction Biology · 2023-04 · 28 (4)
DOI: 10.1111/adb.13271 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Addiction Biology, 2023-03. Verfasst von Vitor S Tardelli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Psiquiatria, Universidade Federal de Sao Paulo (Unifesp), Sao Paulo, SP, Brazil. Hauptthemen laut MEDLINE: Cocaine-Related Disorders, Central Nervous System Stimulants, Prescription Drugs. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institutes of Health, New York State Psychiatric Institute.
Abstract (Originalsprache)
Cocaine use is a public health concern in many countries worldwide, particularly in the Americas and Oceania. Overdose deaths involving stimulants, such as cocaine, have been increasing markedly in North America, especially with concurrent opioid involvement. To date, no pharmacological treatment is available to treat stimulant (including cocaine) use disorders. Prescription psychostimulants (PPs) could be useful to treat cocaine use disorder (CUD) as they share the pharmacological effects with cocaine, as evidenced by a recent meta‐analysis that assessed 38 randomized clinical trials (RCTs). PPs were found to promote sustained abstinence and reduce drug use in patients with CUD. The aim of this paper is to provide a narrative review of the clinical pharmacology of PPs and comment on the current stage of evidence supporting PPs to treat CUD. We also propose a model of care that integrates PPs with evidence‐based psychosocial interventions (such as cognitive‐behavioural therapy [CBT] and contingency management [CM]), a harm reduction approach and case management with social support.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Psiquiatria, Universidade Federal de Sao Paulo (Unifesp), Sao Paulo, SP, Brazil.
- Translational Addiction Research Laboratory, Center for Addiction and Mental Health, Toronto, ON, Canada.
- Department of Psychiatry and Human Behavior, University of Mississipi Medical Center, Jackson, MS, USA.
- Mental Health Department, Azienda Unitá Sanitaria Locale, Parma, Italy.
- The Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University and the New York State Psychiatric Institute, New York, NY, USA.
- Young Leaders Program from the National Academy of Medicine, Brazil.
ORCID-Profile: Vitor S Tardelli, Lais F Berro
Förderung
- NIDA NIH HHS
- National Institutes of Health
- New York State Psychiatric Institute
Zitieren
APA
Tardelli, V. S., Berro, L. F., Gerra, G., Tadonio, L., Bisaga, A., & Fidalgo, T. M. (2023). Prescription psychostimulants for cocaine use disorder: A review from molecular basis to clinical approach. Addiction Biology, 28(4). https://doi.org/10.1111/adb.13271
Vancouver
Tardelli VS, Berro LF, Gerra G, Tadonio L, Bisaga A, Fidalgo TM. Prescription psychostimulants for cocaine use disorder: A review from molecular basis to clinical approach. Addiction Biology. 2023;28(4). doi:10.1111/adb.13271
BibTeX
@article{Tardelli2023,
author = {Tardelli, Vitor S and Berro, Lais F and Gerra, Gilberto and Tadonio, Leonardo and Bisaga, Adam and Fidalgo, Thiago M},
title = {Prescription psychostimulants for cocaine use disorder: A review from molecular basis to clinical approach},
journal = {Addiction Biology},
year = {2023},
volume = {28},
number = {4},
doi = {10.1111/adb.13271}
}
EUVIMED